Cencora Inc

COR: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|!hLOCK|cW#LLOCK|jz^Q>K

Cencora: OneOncology Investment Looks Strategically Sound for Long-term Growth

Cencora announced it will acquire the majority of the outstanding equity interest of OneOncology for roughly $5 billion. Cencora and TPG formed a joint venture to initially acquire OneOncology together in June 2023. Cencora at the time paid $720 million to acquire 35% of the JV.

Sponsor Center